Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLEU NASDAQ:IPXX NASDAQ:UROY NASDAQ:VACH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLEUbleuacacia$11.03$11.05$10.70▼$11.59$83.39M0.013,271 shsN/AIPXXInflection Point Acquisition Corp. II$14.26-8.2%$10.78$9.24▼$15.25$445.63M0.1797,243 shs10.89 million shsUROYUranium Royalty$2.62-0.2%$2.29$1.43▼$3.12$350.81M1.312.48 million shs805,778 shsVACHVoyager Acquisition$10.39-0.2%$10.36$9.95▼$11.20$328.58MN/A116,999 shs8,945 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLEUbleuacacia0.00%0.00%0.00%0.00%+2.60%IPXXInflection Point Acquisition Corp. II+20.34%+45.66%+2.08%+1.21%+34.15%UROYUranium Royalty+2.34%+11.97%+6.50%+45.56%+5.65%VACHVoyager Acquisition-0.09%+0.05%+0.10%+1.46%+1,038,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLEUbleuacaciaN/AN/AN/AN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/AN/AN/AN/AUROYUranium Royalty2.6902 of 5 stars3.55.00.00.03.30.00.0VACHVoyager AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLEUbleuacacia 0.00N/AN/AN/AIPXXInflection Point Acquisition Corp. II 4.00Strong BuyN/AN/AUROYUranium Royalty 3.00Buy$4.0052.96% UpsideVACHVoyager Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BLEU, IPXX, VACH, and UROY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/22/2025UROYUranium RoyaltyHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.70 ➝ $4.50(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLEUbleuacaciaN/AN/A$0.56 per share19.70($1.64) per shareN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/AN/AUROYUranium Royalty$11.19M31.23$0.06 per share42.51$1.69 per share1.55VACHVoyager AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLEUbleuacacia$3.86MN/A58.05∞N/AN/A-6.04%4.62%N/AIPXXInflection Point Acquisition Corp. IIN/AN/A0.00∞N/AN/AN/AN/AN/AUROYUranium Royalty$7.24MN/AN/A261.50N/AN/A-1.99%-1.93%7/23/2025 (Estimated)VACHVoyager AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ALatest BLEU, IPXX, VACH, and UROY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/23/2025Q4 2025UROYUranium Royalty-$0.01-$0.01N/A-$0.01N/A$3.30 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLEUbleuacaciaN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/AUROYUranium RoyaltyN/AN/AN/AN/AN/AVACHVoyager AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLEUbleuacaciaN/A0.040.04IPXXInflection Point Acquisition Corp. IIN/AN/AN/AUROYUranium RoyaltyN/A216.6216.30VACHVoyager AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLEUbleuacacia13.89%IPXXInflection Point Acquisition Corp. IIN/AUROYUranium Royalty24.19%VACHVoyager AcquisitionN/AInsider OwnershipCompanyInsider OwnershipBLEUbleuacacia0.94%IPXXInflection Point Acquisition Corp. II20.00%UROYUranium RoyaltyN/AVACHVoyager AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLEUbleuacacia47.56 million7.49 millionNot OptionableIPXXInflection Point Acquisition Corp. IIN/A31.25 million25.00 millionNot OptionableUROYUranium Royalty10133.64 millionN/AOptionableVACHVoyager AcquisitionN/A31.63 millionN/AN/ABLEU, IPXX, VACH, and UROY HeadlinesRecent News About These CompaniesVERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SECJuly 17 at 8:55 AM | globenewswire.comXlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4July 17 at 3:28 AM | pharmiweb.comPVERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SECJuly 17 at 2:00 AM | globenewswire.comWealthspring Capital LLC Sells 24,668 Shares of Voyager Acquisition Corp. (NASDAQ:VACH)July 15 at 9:28 AM | marketbeat.comVACH Voyager Acquisition Corp. - Seeking AlphaJuly 10, 2025 | seekingalpha.comVoyager Acquisition (NASDAQ:VACH) Trading Down 0.1% - Here's WhyJune 28, 2025 | marketbeat.comVoyager Acquisition Corp. Cl A (VACH) Stock Price Today - WSJJune 27, 2025 | wsj.comSpace Firm Voyager Technologies Surges 139% After Upsized IPOJune 11, 2025 | msn.comVoyager launches IPO with $1.6 billion valuation targetJune 3, 2025 | spacenews.comSVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29, 2025 | globenewswire.comVERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology PlatformMay 29, 2025 | globenewswire.comVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | globenewswire.comVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | manilatimes.netMVoyager Acquisition Corp.: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 6, 2025 | finanznachrichten.deVERAXA Biotech GmbH: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 5, 2025 | finanznachrichten.deVeraxa to go public in $1.6bn SPAC deal with VoyagerApril 23, 2025 | msn.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVeraxa Biotech to merge with SPAC Voyager in $1.64 billion dealApril 23, 2025 | msn.comFrom Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to merge with Voyager Acquisition Corp. listed on NASDAQApril 23, 2025 | markets.businessinsider.comXlife Sciences’ VERAXA Biotech to Merge with Voyager Acquisition Corp.April 23, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBLEU, IPXX, VACH, and UROY Company Descriptionsbleuacacia NASDAQ:BLEUbleuacacia ltd does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of premium branded consumer retail. The company was incorporated in 2021 and is based in New York, New York.Inflection Point Acquisition Corp. II NASDAQ:IPXX$14.26 -1.28 (-8.24%) As of 07/16/2025Inflection Point Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2023 and is based in New York, New York.Uranium Royalty NASDAQ:UROY$2.62 -0.01 (-0.19%) As of 12:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. The company has royalty interests in the McArthur River, Cigar Lake / Waterbury Lake, Roughrider, Russell Lake, Russell Lake south, and Dawn Lake projects in Saskatchewan, Canada; Anderson and San Rafael projects in Arizona; Lance and Reno Creek projects in Wyoming; Church Rock and Roca Honda projects in New Mexico; Dewey-Burdock project in South Dakota; Slick Rock project in Colorado; Langer Heinrich project in Namibia; and Michelin project in Newfoundland and Labrador, Canada; Energy Queen and Whirlwind project in Utah; and Workman Creek projects in Arizona. Uranium Royalty Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.Voyager Acquisition NASDAQ:VACH$10.39 -0.02 (-0.19%) As of 11:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Voyager Acquisition Corp. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Voyager Acquisition Corp. is based in BROOKLYN, N.Y. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap How Goldman Sachs Earnings Help You Strategize Your Portfolio Is Amazon Really the Best Forever Stock for Your Portfolio? Full Steam Ahead: The Bullish Case for Carnival Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
